Camptothecin (CPT)
Camptothecin (CPT) is a specific inhibitor of DNA topoisomerase I (Topo I) with IC50 of 0.68 μM in a cell-free assay. Camptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathways. Phase 2.
| Trivial name | Campathecin, (S)-(+)-Camptothecin,NSC-100880 |
| Catalog Number | S1288 |
| Molecular Formula | C19H14F2N4O2 |
| CAS# | 7689-03-4 |
| Inchi | InChI=1S/C19H14F2N4O2/c1-2-18(26)24-16-9-13(7-8-14(16)20)23-19(27)12-10-22-25(11-12)17-6-4-3-5-15(17)21/h2-11H,1H2,(H,23,27)(H,24,26) |
| Inchi Key | SUSXQEYPNDORDQ-UHFFFAOYSA-N |
| SMILES | C=CC(=O)NC1=C(C=CC(=C1)NC(=O)C2=CN(N=C2)C3=CC=CC=C3F)F |
| Size | 500mg |
| Supplier Page | http://www.selleckchem.com/products/Camptothecine.html |
| Additional Information | https://file.selleck.cn/downloads/struct/Camptothecine-chemical-structure-S1288.gif |